Yuyan Jin
Company: SanegeneBio
Job title: Senior Vice President & Head of Non-Clinical & Clinical Development
Seminars:
Reviewing the Advancements of siRNA-based Therapeutics to Treat Complement-Mediated Kidney Disease 10:15 am
Highlighting the potential of RNA interference-based therapeutics in modulating complement-driven kidney diseases and offer insights into their mechanism of action Exploring the unique advantages of siRNA technology for complement inhibition in kidney disease, such as potentially targeted delivery and sustained effect Touching upon challenges and best practices in conducting large Phase 3 trialsRead more
day: Conference Day One